MAGEB2 and hepatocellular carcinoma: Furthermore, MAGEB2 can improve the stress tolerance of tumor cells by inhibiting the synthesis of stress granules (Lee et al. 2020); PAGE1 is also highly expressed in HCC cells and is considered as a potential biomarker and therapeutic target (Cui and Jiang 2022).